Clinical Trial Update: Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation

View source ↗

Summary

A completed clinical trial evaluating the pharmacokinetic characteristics of intravenous Hepabig injection used to prevent hepatitis B relapse after liver trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Liver Cirrhosis

Drugs mentioned

• Hepabig Injection

Snippet

Sponsor: Dong-Gu Kim | Conditions: Liver Cirrhosis, Chronic Hepatitis B | Status: COMPLETED